Respiratory Tract Diseases
101
7
14
58
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
13 trials with published results (13%)
Research Maturity
58 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.9%
7 terminated out of 101 trials
89.2%
+2.7% vs benchmark
15%
15 trials in Phase 3/4
22%
13 of 58 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 58 completed trials
Clinical Trials (101)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Collection of Lung Fluid and Tissue Samples for Research
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
Real World Registry for Use of the Ion Endoluminal System
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
Cross-sectional Characterization of Idiopathic Bronchiectasis
Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC
Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)
AeviceMD for Detection of Wheeze in Pediatric and Adult Populations
Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Daily Vitamin D for Sickle-cell Respiratory Complications
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Early Intervention Strategies for Lung Cancer